Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.

ABSTRACT:

SUBMITTER: Tashkin DP 

PROVIDER: S-EPMC5014629 | biostudies-literature | 2016 Sep

REPOSITORIES: biostudies-literature